+ Phase-I-support-Safety-pharmacology

Safety pharmacology

We work closely with our expert partner CERB to assess primary and secondary functions, including standard core-battery assessments and specialised, non-standard pharmacology.


We routinely manage safety pharmacology studies, generally as part of “first-in-man” non-clinical programmes.  These studies are not conducted in-house but are sub-contracted to a partner organisation with specialist experience in this area.  Our preferred partner is CERB.

CERB has more than 100 models/methods established for the assessment of primary and secondary functions or safety of new drug candidates. http://www.cerb.fr/index.html

  • Primary pharmacology
  • Proof of concept
  • Disease models
  • Early safety pharmacology
  • ICH S7A Core battery

Our News & Events
Biomarker Validation – Mountain, Molehill or Something in Between?
13 June 2018
Biomarker Validation – Mountain, Molehill or Something in Between?
Read More
More sex, more strain and we are all a bit older…
19 April 2018
Immunophenotyping of lymphocyte subsets
Read More
Moving to Minipigs?
29 March 2018
Moving to Minipigs?
Read More